552 related articles for article (PubMed ID: 16143964)
1. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
3. Comparison of UV and charged aerosol detection approach in pharmaceutical analysis of statins.
Nováková L; Lopéz SA; Solichová D; Satínský D; Kulichová B; Horna A; Solich P
Talanta; 2009 May; 78(3):834-9. PubMed ID: 19269437
[TBL] [Abstract][Full Text] [Related]
4. Not all statins interfere with clopidogrel during antiplatelet therapy.
Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
[TBL] [Abstract][Full Text] [Related]
5. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study.
Cheung RC; Morrell JM; Kallend D; Watkins C; Schuster H
Int J Cardiol; 2005 Apr; 100(2):309-16. PubMed ID: 15823640
[TBL] [Abstract][Full Text] [Related]
6. Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS.
Gerber R; Ryan JD; Clark DS
Anal Biochem; 2004 Jun; 329(1):28-34. PubMed ID: 15136164
[TBL] [Abstract][Full Text] [Related]
7. Chromatography-mass spectrometry methods for the quantitation of statins in biological samples.
Nirogi R; Mudigonda K; Kandikere V
J Pharm Biomed Anal; 2007 Jun; 44(2):379-87. PubMed ID: 17433599
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin.
Silva TD; Oliveira MA; de Oliveira RB; Vianna-Soares CD
J Chromatogr Sci; 2012 Oct; 50(9):831-8. PubMed ID: 22689902
[TBL] [Abstract][Full Text] [Related]
9. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
Morris MJ; Gilbert JD; Hsieh JY; Matuszewski BK; Ramjit HG; Bayne WF
Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499
[TBL] [Abstract][Full Text] [Related]
10. Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies.
Kumar TR; Shitut NR; Kumar PK; Vinu MC; Kumar VV; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Sep; 20(9):881-7. PubMed ID: 16389642
[TBL] [Abstract][Full Text] [Related]
11. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
Verhulst A; D'Haese PC; De Broe ME
J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia.
Cheng-Lai A
Heart Dis; 2003; 5(1):72-8. PubMed ID: 12549990
[TBL] [Abstract][Full Text] [Related]
17. Spectrophotometric determination of rosuvastatin calcium in tablets.
Uyar B; Celebier M; Altinoz S
Pharmazie; 2007 Jun; 62(6):411-3. PubMed ID: 17663185
[TBL] [Abstract][Full Text] [Related]
18. HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.
Shen HR; Li ZD; Zhong MK
Pharmazie; 2006 Jan; 61(1):18-20. PubMed ID: 16454200
[TBL] [Abstract][Full Text] [Related]
19. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]